Eureka Therapeutics provides custom services for the production of recombinant monoclonal antibodies in mammalian (CHO) cells in amounts ranging from 1-2 mg to 1-10 grams. The antibodies produced are assayed for purity and certified to possess low-endotoxin and nucleic acid levels suitable for preclinical animal studies.
Eureka's state-of-the-art facilities and technical expertise enable the production of:
| Amount of antibody | Timeline |
| 1-2 mgs | 30 days |
| 100-200 mgs | 2 months |
| 1-10 g | 5 months |
Please contact us for more information.